Vaccine Education Center

Related News

HPV Vaccine Safety

Update - November 2008

The human papillomavirus (HPV) vaccine has been recommended for use in 9- to 26-year old females for two years. During this time, several systems have been in place to monitor vaccine safety. In a recent meeting at the Centers for Disease Control and Prevention (CDC), the public learned what each of these systems had found:

Posted: November 2008

  • Print
  • Share

Contact Us

We would like to hear from you, please use our online form to contact us with questions or comments.